Enlivex Therapeutics Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Ness Ziona Israel (2005)

Organization Overview

First Clinical Trial
2019
NCT03925857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Enlivex Therapeutics Ltd. | Enlivex Therapeutics LTD Email:mevorachd@gmail.com | Enlivex Therapeutics R&D | Enlivex Therapeutics RDO Ltd.